A new series of cysLT(1) receptor antagonists represented by CP-288,886 (7)
and CP-265,298 (8) were developed which are equipotent to clinical cysLT(1
) receptor antagonists Zafirlukast (1) and Pranlukast (2). (C) 1998 Elsevie
r Science Ltd. All rights reserved.